KUALA LUMPUR: Duopharma Biotech Bhd
’s net profit rose 20% to RM16.96mil in the third quarter ended Sept 30, from RM14.12mil a year ago.
The improved performance was mainly due to higher demand from consumer healthcare and the public health sector.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
